Endoscopic Myotomy for Achalasia Treatment
Official title: Peroral Endoscopic Myotomy for the Treatment of Achalasia: A Single-center Registry
Run by Methodist Health System · NCT04640753 · Data updated 2026-11-12
This study looks at how well a specific procedure called endoscopic myotomy works for treating achalasia in patients who have already had the treatment at Methodist Dallas Medical Center.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | February 6, 2019 |
| Main results expected | February 5, 2027 |
| Study ends | February 5, 2027 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT04640753 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have undergone POEM for achalasia between June 2016 and June 2021.
✕Probably not a fit
Patients who have not undergone POEM for achalasia or are under 18 years of age will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves a retrospective and prospective chart review of patients who have undergone peroral endoscopic myotomy (POEM) for achalasia at Methodist Dallas Medical Center. The retrospective review covers patients treated between June 2016 and January 2019, while the prospective review includes patients treated from February 2019 to June 2021. Data will be collected from electronic health records without any additional tests or procedures required for participants. All subjects will be consented for participation, and their data will be de-identified to protect personal health information.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the effectiveness and outcomes of POEM for achalasia, potentially leading to improved treatment protocols.
How similar studies have gone: Other studies have shown promising results with similar endoscopic procedures for achalasia, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any discharged patient who has undergone clinically indicated and/or standard of care POEM for the treatment of Achalasia from 6/2016 to 6/2021. * Above or equal to 18 years of age Exclusion Criteria: * Any patient who has not undergone POEM for the treatment of Achalasia. * Below 18 years of age
Where it's running
-
Methodist Dallas Medical Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Prashant Kedia, M.D. — The Methodist Hospital Research Institute
- Study coordinator: Crystee Cooper, DHEd
- Email: clinicalresearch@mhd.com
- Phone: 214-947-1280
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Full-thickness vs progressive myotomy in POEM for achalasia
This trial tests whether a full-thickness myotomy during POEM works better than a partial, progressive approach for people with achalasia, to see which method better relieves symptoms with fewer side effects.
-
Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults
This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
-
Speedboat UltraSlim™ for POEM in adults with achalasia and other esophageal motility disorders.
This registry will see if using the Speedboat UltraSlim™ device for POEM is safe and effective for adults with achalasia or other esophageal motility disorders.
-
Using the SpydrBlade Flex device during POEM for achalasia and EGJ outflow obstruction
This will test whether using the SpydrBlade Flex device during POEM is safe and effective for adults with achalasia or EGJ outflow obstruction.
-
Indocyanine green fluorescence during laparoscopic Heller–Dor for achalasia
This study will try using indocyanine green dye during laparoscopic Heller‑Dor in adults with type I or II achalasia to find mucosal leaks during surgery and help guide repairs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.